Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
amlodipine + metoprolol succinate
- Development stage
- Unknown
- Lead developer
- Gadin Biotech
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Dinmet-XL AM is a fixed-dose combination drug containing amlodipine, a dihydropyridine calcium channel blocker, and metoprolol succinate, a cardioselective beta-1 adrenergic receptor blocker. Developed and manufactured by Gadin Biotech, it is formulated as an extended-release tablet. Amlodipine acts by inhibiting the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle, leading to vasodilation and reduced peripheral resistance. Metoprolol succinate reduces heart rate, cardiac output, and blood pressure by competitively blocking beta-1 receptors. This combination is primarily indicated for the management of hypertension and chronic stable angina, providing synergistic blood pressure control and cardiovascular protection.
- Brand names
- Dinmet-XL AM
- Other names
- Amlodipine and Metoprolol Succinate Extended Release Tablets
02
Targets
CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)ADRB1 (β1)ADRB2 (β2)
Beyond the preview
Go deeper on amlodipine + metoprolol succinate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on amlodipine + metoprolol succinate.